These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 26970668)

  • 1. Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation.
    Sackett SD; Brown ME; Tremmel DM; Ellis T; Burlingham WJ; Odorico JS
    Transplant Rev (Orlando); 2016 Apr; 30(2):61-70. PubMed ID: 26970668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [At Home among Strangers: Is It Possible to Create Hypoimmunogenic Pluripotent Stem Cell Lines?].
    Bogomiakova ME; Eremeev AV; Lagarkova MA
    Mol Biol (Mosk); 2019; 53(5):725-740. PubMed ID: 31661474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological Issues After Stem Cell-Based β Cell Replacement.
    Sordi V; Pellegrini S; Piemonti L
    Curr Diab Rep; 2017 Sep; 17(9):68. PubMed ID: 28726153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.
    Araki R; Uda M; Hoki Y; Sunayama M; Nakamura M; Ando S; Sugiura M; Ideno H; Shimada A; Nifuji A; Abe M
    Nature; 2013 Feb; 494(7435):100-4. PubMed ID: 23302801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief Report: Immune Microenvironment Determines the Immunogenicity of Induced Pluripotent Stem Cell Derivatives.
    Todorova D; Kim J; Hamzeinejad S; He J; Xu Y
    Stem Cells; 2016 Feb; 34(2):510-5. PubMed ID: 26439188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of immune response on the use of iPSCs in disease modeling.
    Zhang Z; Huang B; Gao F; Zhang R
    Curr Stem Cell Res Ther; 2015; 10(3):236-44. PubMed ID: 25019961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in cellular reprogramming: moving toward a reprieve from immunogenicity.
    Gallegos TF; Sancho-Martinez I; Izpisua Belmonte JC
    Immunol Lett; 2013; 155(1-2):14-7. PubMed ID: 24076314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced pluripotent stem cells and their implication for regenerative medicine.
    Csobonyeiova M; Polak S; Koller J; Danisovic L
    Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of Immune Tolerance to Autologous iPSCs and Their Differentiated Derivatives.
    Bogomiakova ME; Bogomazova AN; Lagarkova MA
    Biochemistry (Mosc); 2024 May; 89(5):799-816. PubMed ID: 38880643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells.
    Guha P; Morgan JW; Mostoslavsky G; Rodrigues NP; Boyd AS
    Cell Stem Cell; 2013 Apr; 12(4):407-12. PubMed ID: 23352605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of induced pluripotent stem cell transplants: Autologous or allogeneic?
    Li C; Chen S; Zhou Y; Zhao Y; Liu P; Cai J
    Life Sci; 2018 Nov; 212():145-149. PubMed ID: 30290185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cell-derived gamete-associated proteins incite rejection of induced pluripotent stem cells in syngeneic mice.
    Kim EM; Manzar G; Zavazava N
    Immunology; 2017 Jun; 151(2):191-197. PubMed ID: 28185259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cells derived from iPSC can be immunogenic - yes or no?
    Cao J; Li X; Lu X; Zhang C; Yu H; Zhao T
    Protein Cell; 2014 Jan; 5(1):1-3. PubMed ID: 24474200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of syngeneic and allogeneic iPSC-derived neural precursors after spinal grafting in minipigs.
    Strnadel J; Carromeu C; Bardy C; Navarro M; Platoshyn O; Glud AN; Marsala S; Kafka J; Miyanohara A; Kato T; Tadokoro T; Hefferan MP; Kamizato K; Yoshizumi T; Juhas S; Juhasova J; Ho CS; Kheradmand T; Chen P; Bohaciakova D; Hruska-Plochan M; Todd AJ; Driscoll SP; Glenn TD; Pfaff SL; Klima J; Ciacci J; Curtis E; Gage FH; Bui J; Yamada K; Muotri AR; Marsala M
    Sci Transl Med; 2018 May; 10(440):. PubMed ID: 29743351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced wound healing promotion by immune response-free monkey autologous iPSCs and exosomes vs. their allogeneic counterparts.
    Lu M; Peng L; Ming X; Wang X; Cui A; Li Y; Wang X; Meng D; Sun N; Xiang M; Chen S
    EBioMedicine; 2019 Apr; 42():443-457. PubMed ID: 30926422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducing iPSCs to escape the dish.
    Barrilleaux B; Knoepfler PS
    Cell Stem Cell; 2011 Aug; 9(2):103-11. PubMed ID: 21816362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential for immunogenicity of autologous induced pluripotent stem cell-derived therapies.
    Scheiner ZS; Talib S; Feigal EG
    J Biol Chem; 2014 Feb; 289(8):4571-7. PubMed ID: 24362036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of individualized immunocompatible endothelial cells from HLA-I-matched human pluripotent stem cells.
    Song C; Wang L; Li Q; Liao B; Qiao W; Li Q; Dong N; Li L
    Stem Cell Res Ther; 2022 Feb; 13(1):48. PubMed ID: 35109922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological considerations for embryonic and induced pluripotent stem cell banking.
    Taylor CJ; Bolton EM; Bradley JA
    Philos Trans R Soc Lond B Biol Sci; 2011 Aug; 366(1575):2312-22. PubMed ID: 21727137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.